{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T15:54:11Z","timestamp":1764777251187,"version":"3.46.0"},"reference-count":14,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med.\n                Technol."],"accepted":{"date-parts":[[2025,10,20]]},"published-print":{"date-parts":[[2025,12]]},"DOI":"10.2967\/jnmt.125.271253","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:40:17Z","timestamp":1762296017000},"page":"281-286","source":"Crossref","is-referenced-by-count":0,"title":["Prostate Cancer Imaging with\n                    <sup>18<\/sup>\n                    F-Flotufolastat"],"prefix":"10.2967","volume":"53","author":[{"given":"David","family":"Gilmore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Tempesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"unstructured":"Prostate diseases. MedlinePlus website. https:\/\/medlineplus.gov\/prostatediseases.html. Accessed October 4, 2025.","key":"2025120307500630000_53.4.281.1"},{"unstructured":"U.S. cancer statistics prostate cancer stat bite. Centers for Disease Control and Prevention website. https:\/\/www.cdc.gov\/united-states-cancer-statistics\/publications\/prostate-cancer-stat-bite.html. Accessed August 2, 2025.","key":"2025120307500630000_53.4.281.2"},{"unstructured":"Prostate cancer. American Cancer Society website. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer.html. Accessed August 2, 2025.","key":"2025120307500630000_53.4.281.3"},{"doi-asserted-by":"publisher","key":"2025120307500630000_53.4.281.4","DOI":"10.14740\/wjon1191"},{"doi-asserted-by":"publisher","key":"2025120307500630000_53.4.281.5","DOI":"10.1101\/gad.315739.118"},{"unstructured":"Axumin [package insert]. Oxford, England: Blue Earth Diagnostics; 2016.","key":"2025120307500630000_53.4.281.6"},{"doi-asserted-by":"publisher","key":"2025120307500630000_53.4.281.7","DOI":"10.3389\/fonc.2022.829050"},{"key":"2025120307500630000_53.4.281.8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00259-019-04614-y","article-title":"[18F]fluciclovine PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging\u2014version 1.0","volume":"47","author":"Nanni","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"unstructured":"Posluma [package insert]. Oxford, England: Blue Earth Diagnostics; 2023.","key":"2025120307500630000_53.4.281.9"},{"key":"2025120307500630000_53.4.281.10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.eururo.2023.06.018","article-title":"Diagnostic performance and safety of positron emission tomography with 18F-RHPSMA-7.3 in patients with newly diagnosed unfavourable intermediate- to very-high-risk prostate cancer: results from a phase 3, prospective, multicentre study (LIGHTHOUSE)","volume":"84","author":"Surasi","year":"2023","journal-title":"Eur Urol."},{"key":"2025120307500630000_53.4.281.11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/JU.0000000000003598","article-title":"Diagnostic performance and safety of 18F-RHPSMA-7.3 positron emission tomography in men with suspected prostate cancer recurrence: results from a phase 3, prospective, multicenter study (SPOTLIGHT)","volume":"210","author":"Jani","year":"2023","journal-title":"J Urol."},{"key":"2025120307500630000_53.4.281.12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11307-023-01867-w","article-title":"Quantitative and qualitative assessment of urinary activity of 18F-flotufolastat-PET\/CT in patients with prostate cancer: a post hoc analysis of the LIGHTHOUSE and SPOTLIGHT studies","volume":"26","author":"Kuo","year":"2024","journal-title":"Mol Imaging Biol."},{"unstructured":"Pluvicto [package insert]. Milburn, NJ: Novartis; 2023.","key":"2025120307500630000_53.4.281.13"},{"doi-asserted-by":"publisher","key":"2025120307500630000_53.4.281.14","DOI":"10.3390\/molecules27175730"}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.125.271253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T15:50:19Z","timestamp":1764777019000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.125.271253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,3]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.2967\/jnmt.125.271253"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.125.271253","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"type":"print","value":"0091-4916"},{"type":"electronic","value":"1535-5675"}],"subject":[],"published":{"date-parts":[[2025,11,4]]}}}